Best The Suave Show Podcasts (2024)

1
Teaching AI to Think Like Humans and Make Trade-Offs will Transform Healthcare with Fadi Micaelian Sparkdit TRANSCRIPT

12m ago

—

Fadi Micaelian, CEO of Sparkdit, teaches machines to think like humans by understanding trade-offs. AI is not good at finding nuance and capturing trade-offs, which is where Sparkdit comes in. They have developed a technology that can teach computers to make trade-offs like humans and put humans at the center of the technology rather than replacing…

1
Teaching AI to Think Like Humans and Make Trade-Offs will Transform Healthcare with Fadi Micaelian Sparkdit 18:46

21m ago18:46

18:46

Fadi Micaelian, CEO of Sparkdit, teaches machines to think like humans by understanding trade-offs. AI is not good at finding nuance and capturing trade-offs, which is where Sparkdit comes in. They have developed a technology that can teach computers to make trade-offs like humans and put humans at the center of the technology rather than replacing…

1
Harnessing the Power of Bioactives to Improve Health Outcomes with Sofia Elizondo Brightseed TRANSCRIPT

4d ago

—

Sofia Elizondo, COO and Co-Founder of Brightseed, discusses the company's focus on bioactives and their potential to improve health outcomes. Bioactives are small molecules found in nature, such as plants, fungi, or bacteria, that activate human biological receptors and positively affect the body. Brightseed uses its AI platform, Forager, to identi…

1
Harnessing the Power of Bioactives to Improve Health Outcomes with Sofia Elizondo Brightseed 17:57

4d ago17:57

17:57

Sofia Elizondo, COO and Co-Founder of Brightseed, discusses the company's focus on bioactives and their potential to improve health outcomes. Bioactives are small molecules found in nature, such as plants, fungi, or bacteria, that activate human biological receptors and positively affect the body. Brightseed uses its AI platform, Forager, to identi…

1
Bridging the Gap Between Drug Discovery and Marketing with Luke Piggott Debiopharm TRANSCRIPT

1h ago

—

Luke Piggott, principal scientist at Debiopharm, has a unique business model in the drug discovery and development to commercialization landscape. Focusing on rare cancers, they license drugs from smaller biotechs and conduct clinical trials before out-licensing them to larger pharmaceutical companies with marketing capabilities. The use of AI is e…

1
Bridging the Gap Between Drug Discovery and Marketing with Luke Piggott Debiopharm 15:50

1h ago15:50

15:50

Luke Piggott, principal scientist at Debiopharm, has a unique business model in the drug discovery and development to commercialization landscape. Focusing on rare cancers, they license drugs from smaller biotechs and conduct clinical trials before out-licensing them to larger pharmaceutical companies with marketing capabilities. The use of AI is e…

1
Providing Financial Assistance to Patients with Rare Diseases and Chronic Conditions with Tiara Green Accessia Health TRANSCRIPT

20m ago

—

Tiara Green, President of Accessia Health, provides financial assistance for copayments, physician visits, durable medical equipment, radiology testing, and travel expenses to support individuals with rare and chronic healthcare conditions who cannot afford their care. They also offer educational services to help patients navigate the healthcare sy…

1
Providing Financial Assistance to Patients with Rare Diseases and Chronic Conditions with Tiara Green Accessia Health 15:07

22m ago15:07

15:07

Tiara Green, President of Accessia Health, provides financial assistance for copayments, physician visits, durable medical equipment, radiology testing, and travel expenses to support individuals with rare and chronic healthcare conditions who cannot afford their care. They also offer educational services to help patients navigate the healthcare sy…

1
128 SOUL FAMILY: SUNRU & VEGA 1:36:14

1d ago1:36:14

1:36:14

In today’s episode I sit down with Sunru and Vega. Two of my brothers who are stewards of the collective through their art ,intentionality while honoring Mother Nature as a spiritual practice. Vega is a subconscious healer, artist and energy worker originally from France. He is also the Co- Founder of Flow State - an art collective ,healing Temple …

1
Options for Identifying and Treating Bipolar Disease with Roger Rivera Mente Suave Psychiatry TRANSCRIPT

1h ago

—

Roger Rivera, psychiatric mental health nurse practitioner at Mente Suave Psychiatry, discusses the different types of bipolar disorder, the potential causes of the disease, available treatment options, and the importance of early detection and management. Roger emphasizes the need for a comprehensive approach to care and highlights the impact of b…

1
Options for Identifying and Treating Bipolar Disease with Roger Rivera Mente Suave Psychiatry 18:19

1h ago18:19

18:19

Roger Rivera, psychiatric mental health nurse practitioner at Mente Suave Psychiatry, discusses the different types of bipolar disorder, the potential causes of the disease, available treatment options, and the importance of early detection and management. Roger emphasizes the need for a comprehensive approach to care and highlights the impact of b…

1
Anti-Obesity Drug Targets the CB1 Receptor via the Endocannabinoid System with Punit Dhillon Skye Bioscience TRANSCRIPT

5d ago

—

Punit Dhillon, Chairman and CEO of Skye Bioscience, focuses on anti-obesity and developing a drug that targets the cannabinoid receptor 1, which plays a role in signaling the body to store fat. The next generation of CB1 inhibition moves from a centrally mediated pathway to targeting CB1 receptors outside the brain. Deploying the endocannabinoid sy…

1
Anti-Obesity Drug Targets the CB1 Receptor via the Endocannabinoid System with Punit Dhillon Skye Bioscience 16:58

2h ago16:58

16:58

Punit Dhillon, Chairman and CEO of Skye Bioscience, focuses on anti-obesity and developing a drug that targets the cannabinoid receptor 1, which plays a role in signaling the body to store fat. The next generation of CB1 inhibition moves from a centrally mediated pathway to targeting CB1 receptors outside the brain. Deploying the endocannabinoid sy…

1
Antibody Drug Conjugate Targets Claudin 18.2 to Treat Gastric Cancer with Joe Ferra Elevation Oncology TRANSCRIPT

1h ago

—

Joe Ferra, CEO of Elevation Oncology, highlights the unmet needs in gastric cancer and the potential of targeting Claudins, proteins involved in cell adhesion. The current competitive landscape of antibody drug conjugates (ADCs) confirms the promise of a targeted therapy that delivers a cytotoxic drug directly to cancer cells. Targeting Claudin 18.…

1
Antibody Drug Conjugate Targets Claudin 18.2 to Treat Gastric Cancer with Joe Ferra Elevation Oncology 18:01

1h ago18:01

18:01

Joe Ferra, CEO of Elevation Oncology, highlights the unmet needs in gastric cancer and the potential of targeting Claudins, proteins involved in cell adhesion. The current competitive landscape of antibody drug conjugates (ADCs) confirms the promise of a targeted therapy that delivers a cytotoxic drug directly to cancer cells. Targeting Claudin 18.…

1
Role of AI and Pharmacists in Medication Therapy Optimization with Dr. Steve Goldberg DecisionRx and Jamie Wilkey TRANSCRIPT

1d ago

—

Dr. Steve Goldberg, physician and Senior Clinical Advisor at DecisionRx, and Dr. Jamie Wilkey, pharmacist and expert on medication therapy optimization, explain that medications are the fourth leading cause of death in the country. They emphasize the need to consider genetic information and pharmacogenomics to design personalized medication plans t…

1
Role of AI and Pharmacists in Medication Therapy Optimization with Dr. Steve Goldberg DecisionRx and Jamie Wilkey 16:23

3h ago16:23

16:23

Dr. Steve Goldberg, physician and Senior Clinical Advisor at DecisionRx, and Dr. Jamie Wilkey, pharmacist and expert on medication therapy optimization, explain that medications are the fourth leading cause of death in the country. They emphasize the need to consider genetic information and pharmacogenomics to design personalized medication plans t…

1
Taking the Guesswork Out of Medical Bills and Providing Patient Payment Options with Ryne Natzke TrustCommerce TRANSCRIPT

3d ago

—

Ryne Natzke is the Chief Revenue Officer for TrustCommerce, a Sphere company that facilitates electronic payments in the healthcare industry, helping ensure security and compliance in transactions between patients and providers. Healthcare payments present unique challenges, as patients have varying preferences and are impacted by economic factors …

1
Taking the Guesswork Out of Medical Bills and Providing Patient Payment Options with Ryne Natzke TrustCommerce 17:50

12d ago17:50

17:50

Ryne Natzke is the Chief Revenue Officer for TrustCommerce, a Sphere company that facilitates electronic payments in the healthcare industry, helping ensure security and compliance in transactions between patients and providers. Healthcare payments present unique challenges, as patients have varying preferences and are impacted by economic factors …

1
Medical Marketplace for Hospitals and Surgery Centers of Stale or Excess Inventory Saves Money Reduces Waste with Dr. Andrew Dold RevMed TRANSCRIPT

4d ago

—

Dr. Andrew Dold, Co-Founder of RevMed, a B2B marketplace for hospitals and ambulatory surgery centers (ASCs) to address the problem of slow-moving or expiring inventory. This medical marketplace allows facilities to recoup lost revenue by listing medical devices for sale and offers purchasing options for smaller facilities. RevMed serves as a middl…

1
Medical Marketplace for Hospitals and Surgery Centers of Stale or Excess Inventory Saves Money Reduces Waste with Dr. Andrew Dold RevMed 16:12

4d ago16:12

16:12

Dr. Andrew Dold, Co-Founder of RevMed, a B2B marketplace for hospitals and ambulatory surgery centers (ASCs) to address the problem of slow-moving or expiring inventory. This medical marketplace allows facilities to recoup lost revenue by listing medical devices for sale and offers purchasing options for smaller facilities. RevMed serves as a middl…

1
Unlocking Secrets of the Ocean for Marine-Based Research and Drug Discovery with Ed Esquenazi Sirenas TRANSCRIPT

10d ago

—

Ed Esquenazi, Founder and CEO of Sirenas, is exploring the chemistry of marine organisms to accelerate drug discovery. Marine-based scientific elements are still poorly understood but have the potential to produce unique and useful compounds for drug development. There are stark differences between land-based organisms and marine-based organisms, w…

1
Unlocking Secrets of the Ocean for Marine-Based Research and Drug Discovery with Ed Esquenazi Sirenas 16:36

5d ago16:36

16:36

Ed Esquenazi, Founder and CEO of Sirenas, is exploring the chemistry of marine organisms to accelerate drug discovery. Marine-based scientific elements are still poorly understood but have the potential to produce unique and useful compounds for drug development. There are stark differences between land-based organisms and marine-based organisms, w…

1
Using Medical AI to Accelerate the Prior Approval Process with Kim Perry emtelligent TRANSCRIPT

10d ago

—

Kim Perry, Chief Growth Officer at emtelligent, focuses on using medical AI in the prior authorization process to structure unstructured medical text in patient records, making whole record healthcare possible. AI can be used to extract relevant information from faxed or PDF medical records, saving time and improving efficiency over existing manual…

1
Using Medical AI to Accelerate the Prior Approval Process with Kim Perry emtelligent 19:44

10d ago19:44

19:44

Kim Perry, Chief Growth Officer at emtelligent, focuses on using medical AI in the prior authorization process to structure unstructured medical text in patient records, making whole record healthcare possible. AI can be used to extract relevant information from faxed or PDF medical records, saving time and improving efficiency over existing manual…

1
Developing Gene Therapy for Friedreich’s Ataxia Cardiomyopathy with Nolan Townsend Lexeo Therapeutics and Jen Farmer FARA TRANSCRIPT

11d ago

—

Nolan Townsend, CEO of Lexeo Therapeutics, and Jen Farmer, CEO of FARA, the Friedreich's Ataxia Research Alliance, are working together to better understand and treat Friedreich's Ataxia. This rare genetic condition includes cardiomyopathy and scoliosis. Lexeo Therapeutics is studying gene therapy as a potential treatment for the cardiovascular com…

1
Developing Gene Therapy for Friedreich’s Ataxia Cardiomyopathy with Nolan Townsend Lexeo Therapeutics and Jen Farmer FARA 18:20

11d ago18:20

18:20

Nolan Townsend, CEO of Lexeo Therapeutics, and Jen Farmer, CEO of FARA, the Friedreich's Ataxia Research Alliance, are working together to better understand and treat Friedreich's Ataxia. This rare genetic condition includes cardiomyopathy and scoliosis. Lexeo Therapeutics is studying gene therapy as a potential treatment for the cardiovascular com…

1
How Technology Can Streamline Physician Workflow and Improve Patient Care with Dr. Craig Joseph Nordic Global TRANSCRIPT

28d ago

—

Dr. Craig Joseph, Chief Medical Officer at Nordic Global, highlights the concerns and challenges healthcare professionals face when using health IT and the clinician burnout related to the administrative burdens of electronic health records. He addresses the obstacles to integrating IT into healthcare workflows, including cost, risk aversion, and r…

1
How Technology Can Streamline Physician Workflow and Improve Patient Care with Dr. Craig Joseph Nordic Global 23:01

28d ago23:01

23:01

Dr. Craig Joseph, Chief Medical Officer at Nordic Global, highlights the concerns and challenges healthcare professionals face when using health IT and the clinician burnout related to the administrative burdens of electronic health records. He addresses the obstacles to integrating IT into healthcare workflows, including cost, risk aversion, and r…

1
Promoting Natural Repair of Spinal Cord Injury and Restoration of Central Nervous System Connectivity with Mike Kelly NervGen Pharma TRANSCRIPT

1M ago

—

Mike Kelly, CEO of NervGen Pharma, discusses the company's vision to build a startup biotech focused on repairing the central nervous system, helping patients regain function, not just slowing progression. Their first product, NVG-291, is currently in clinical trials for spinal cord injury. The drug candidate aims to promote natural repair by targe…

1
Promoting Natural Repair of Spinal Cord Injury and Restoration of Central Nervous System Connectivity with Mike Kelly NervGen 16:56

1M ago16:56

16:56

Mike Kelly, CEO of NervGen Pharma, discusses the company's vision to build a startup biotech focused on repairing the central nervous system, helping patients regain function, not just slowing progression. Their first product, NVG-291, is currently in clinical trials for spinal cord injury. The drug candidate aims to promote natural repair by targe…

1
Developing Recurring Revenue Health and Wellness Products and Services to Optimize Patient Experience and Build Loyalty with Matt Cronin House of Kaizen TRANSCRIPT

1M ago

—

Matt Cronin, Founding Partner of House of Kaizen, discusses how patients' changing healthcare expectations are shaped by their experiences with products and services such as Netflix and Amazon Prime. Consumers now expect a longer-term relationship and personalized experiences with their healthcare providers. House of Kaizen emphasizes the importanc…

1
Developing Recurring Revenue Health and Wellness Products and Services to Optimize Patient Experience and Build Loyalty with Matt Cronin House of Kaizen 19:59

1M ago19:59

19:59

Matt Cronin, Founding Partner of House of Kaizen, discusses how patients' changing healthcare expectations are shaped by their experiences with products and services such as Netflix and Amazon Prime. Consumers now expect a longer-term relationship and personalized experiences with their healthcare providers. House of Kaizen emphasizes the importanc…

1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology TRANSCRIPT

1M ago

—

Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…

1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology 18:16

1M ago18:16

18:16

Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…

1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma TRANSCRIPT

1M ago

—

Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …

1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma 21:01

1M ago21:01

21:01

Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …

1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health TRANSCRIPT

1M ago

—

Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…

1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health 22:28

1M ago22:28

22:28

Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…

1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation TRANSCRIPT

1M ago

—

Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…

1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation 21:45

1M ago21:45

21:45

Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…

1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis TRANSCRIPT

1M ago

—

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…

1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis 22:08

1M ago22:08

22:08

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…

1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines TRANSCRIPT

1M ago

—

Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …

1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines 19:10

1M ago19:10

19:10

Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …

1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies TRANSCRIPT

1M ago

—

Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…

1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies 21:15

1M ago21:15

21:15

Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…

1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics TRANSCRIPT

2M ago

—

Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…

1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics 19:11

2M ago19:11

19:11

Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…

1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC TRANSCRIPT

2M ago

—

Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …

Podcasts Worth a Listen

The Suave Show Podcasts

Podcasts Worth a Listen

Quick Reference Guide